Cargando…

Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study

BACKGROUND: We investigated changes in clinical characteristics of SGLT2i and GLP-1RA real-world initiators in Denmark before/after landmark cardiovascular outcome trials. METHODS: We compared first-time SGLT2i (25,070) and GLP-1RA (14,671) initiators to initiators of DPP-4i (n = 34,079), a class wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knudsen, Jakob S., Baggesen, Lisbeth M., Lajer, Maria, Nurkanovic, Larisa, Ustyugova, Anastasia, Sørensen, Henrik T., Thomsen, Reimar W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055862/ https://www.ncbi.nlm.nih.gov/pubmed/32130249 http://dx.doi.org/10.1371/journal.pone.0229621

Ejemplares similares

Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study
por: Thomsen, Reimar W., et al.
Publicado: (2021)

Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
por: Funck, Kristian L., et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark
por: Thomsen, Reimar W., et al.
Publicado: (2022)

Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study
por: Mor, Anil, et al.
Publicado: (2016)

SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
por: Anson, Matthew, et al.
Publicado: (2023)

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study
por: Knudsen, Jakob S., et al.
Publicado: (2022)

Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes – a Danish nationwide observational study
por: Falkentoft, Alexander C., et al.
Publicado: (2022)

FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND GLP1-RA IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials: Perspective on GLP-1 RA and SGLT-2i therapies
por: Ludwig, Lisa, et al.
Publicado: (2020)

SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
por: D'Marco, Luis, et al.
Publicado: (2021)

Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
por: Trombara, Filippo, et al.
Publicado: (2023)

FRI648 GLP-1RA And SGLT2i Treatments May Show Improved Depression Metrics In Diabetes Treatment
por: Jain, Arad, et al.
Publicado: (2023)

Monitoring the Comparative Safety of SGLT2i vs GLP-1 RA in Older Adults With Type 2 Diabetes by Frailty Status
por: Kutz, Alexander, et al.
Publicado: (2021)

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
por: Belli, Martina, et al.
Publicado: (2022)

Mortality Among Danish Patients with a Hospital Diagnosis of Overweight or Obesity Over a 40-Year Period
por: Gribsholt, Sigrid Bjerge, et al.
Publicado: (2022)

The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system
por: Nielsen, Jens Steen, et al.
Publicado: (2012)

Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
por: Koike, Masao, et al.
Publicado: (2021)

Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal Protection in Type 2 Diabetes) Cross-Sectional Study
por: Simões de Carvalho, Francisco, et al.
Publicado: (2023)

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease
por: Luo, Jing, et al.
Publicado: (2023)

Healthcare resource utilisation and cost associated with elevated potassium levels: a Danish population-based cohort study
por: Kim, Kun, et al.
Publicado: (2019)

Conceptual framework for a Danish human biomonitoring program
por: Thomsen, Marianne, et al.
Publicado: (2008)

Meta-analysis assessing the effectiveness of SGLT2i+GLP1RA combination therapy versus monotherapy on cardiovascular and cerebrovascular outcomes in diabetic patients
por: Du, Lixin, et al.
Publicado: (2022)

Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study
por: Newman, Terri Victoria, et al.
Publicado: (2021)

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Predictors for pathologically confirmed aortitis after resection of the ascending aorta: A 12-year Danish nationwide population-based cross-sectional study
por: Schmidt, Jean, et al.
Publicado: (2011)

Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
por: Rubak, Sune, et al.
Publicado: (2018)

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
por: Schernthaner, Guntram, et al.
Publicado: (2020)

Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients
por: Søgaard, Mette, et al.
Publicado: (2011)

Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea
por: Kårhus, Martin Lund, et al.
Publicado: (2022)

The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022)

Use of selective serotonin reuptake inhibitors and lifestyle among women of childbearing age: a Danish cross-sectional survey
por: Laugesen, Kristina, et al.
Publicado: (2013)

Danish Register of chronic obstructive pulmonary disease
por: Lange, Peter, et al.
Publicado: (2016)

Venous Thromboembolism after Community-Acquired Bacteraemia: A 20-year Danish Cohort Study
por: Dalager-Pedersen, Michael, et al.
Publicado: (2014)

Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort
por: Pottegård, Anton, et al.
Publicado: (2020)

Accelerometer-derived physical activity and sedentary behaviors in individuals with newly diagnosed type 2 diabetes: A cross-sectional study from the Danish nationwide DD2 cohort
por: Domazet, Sidsel L., et al.
Publicado: (2023)

Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients
por: Wildenschild, Cathrine, et al.
Publicado: (2013)

Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study
por: Kristensen, Frederik Pagh Bredahl, et al.
Publicado: (2023)

Socioeconomic status and survival of cirrhosis patients: A Danish nationwide cohort study
por: Jepsen, Peter, et al.
Publicado: (2009)

Validity of ICD-10 diagnoses of overweight and obesity in Danish hospitals
por: Gribsholt, Sigrid Bjerge, et al.
Publicado: (2019)

Kidney disease and risk of dementia: a Danish nationwide cohort study
por: Kjaergaard, Alisa D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbogj3pdakhafcso2h0195v63v